Publications by authors named "L M Stanger"

Claim this Profile
N
Novel HDAC inhibitor, CS014, attenuates in vivo thrombosis while maintaining hemostasis.
Livia Stanger, Pooja Yalavarthi, Reheman Adili, Devin Gilmore, Timothy Hoang

J Thromb Haemost· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The EPA oxylipin, 12-HEPE, directly regulates human platelet activity.
Krista Goerger, Livia Stanger, Andrew Rickenberg, Anthony Nguyễn, Taekyu Lee

J Lipid Res· May 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Antiplatelet strategies: past, present, and future.
Livia Stanger, Adriana Yamaguchi, Michael Holinstat

J Thromb Haemost· December 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The oxylipin analog CS585 prevents platelet activation and thrombosis through activation of the prostacyclin receptor.
Livia Stanger, Adriana Yamaguchi, Pooja Yalavarthi, Sylviane Lambert, Devin Gilmore

Blood· November 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Investigating the catalytic efficiency of C22-Fatty acids with LOX human isozymes and the platelet response of the C22-oxylipin products.
Michelle Tran, Livia Stanger, Srihari Narendra, Michael Holinstat, Theodore R Holman

Arch Biochem Biophys· October 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis